Cited by 481Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and OutcomesParkinson's Disease Mechanisms and Treatments

PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys

Nader, Michael A, Morgan, Drake, Gage, H Donald, Nader, Susan H, Calhoun, Tonya L, Buchheimer, Nancy, Ehrenkaufer, Richard, Mach, Robert H·2006·Nature Neuroscience

Abstract

Dopamine neurotransmission is associated with high susceptibility to cocaine abuse. Positron emission tomography was used in 12 rhesus macaques to determine if dopamine D2 receptor availability was associated with the rate of cocaine reinforcement, and to study changes in brain dopaminergic function during maintenance of and abstinence from cocaine. Baseline D2 receptor availability was negatively correlated with rates of cocaine self-administration. D2 receptor availability decreased by 15-20% within 1 week of initiating self-administration and remained reduced by approximately 20% during 1 year of exposure. Long-term reductions in D2 receptor availability were observed, with decreases persisting for up to 1 year of abstinence in some monkeys. These data provide evidence for a predisposition to self-administer cocaine based on D2 receptor availability, and demonstrate that the brain dopamine system responds rapidly following cocaine exposure. Individual differences in the rate of recovery of D2 receptor function during abstinence were noted.

Integrity signals

Registry

Crossref · 10.1038/nn1737

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The decrease in D2 receptor binding is long lasting, at least 3-4 months in humans and possibly up to a year in non-human primates depending on the individual.

    “On the other hand, the decrease in D2 receptor binding is long lasting, at least 3–4 months in humans (Volkow et al., 1993) and possibly longer, up to a year in non-human primates depending on the individual (Nader et al., 2006).”
  • Repeated drug exposures in rodents and non-human primates are associated with reductions in striatal D2R levels and D2R signalling.

    “preclinical studies in rodent and non-human primates have shown that repeated drug exposures are associated with reductions in striatal D2R levels and in D2R signalling (65–67).”

    From Obesity and addiction: Neurobiological overlaps (2013) · cites this paper as [66]

  • Repeated drug exposures are associated with long-lasting reductions in striatal D2R levels and signaling in preclinical studies.

    “Similarly, preclinical studies have shown that repeated drug exposures are associated with long-lasting reductions in striatal D2R levels and signaling (72,73).”

    From The Addictive Dimensionality of Obesity (2013) · cites this paper as [72]

  • Preclinical studies in rodent and non-human primates have shown that repeated drug exposures are associated with reductions in striatal D2R levels.

    “Similarly, preclinical studies in rodent and non-human primates have shown that repeated drug exposures are associated with reductions in striatal D2R levels (Nader et al 2006;Thanos et al 2007;Volkow et al 2001).”

    From Food and Drug Reward: Overlapping Circuits in Human Obesity and Addiction (2011) · cites this paper as Nader et al 2006

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nader, M. A., Morgan, D., Gage, H. D., Nader, S. H., Calhoun, T. L., Buchheimer, N., Ehrenkaufer, R., & Mach, R. H.
Affiliations
  • Wake Forest University Health Sciences (US)
  • University of Florida Health (US)
  • Washington University in St. Louis (US)
Corresponding author
Nader, Michael A
Venue
Nature Neuroscience
Published
2006-07-09
Volume
9
Issue
8
Pages
1050-1056
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2125364966
Cited by
481
References
47
Citations by year
2026: 8 · 2025: 14 · 2024: 16 · 2023: 14 · 2022: 13 · 2021: 12 · 2020: 38 · 2019: 17 · 2018: 22 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 25 · 2013: 53 · 2012: 36
FWCI
9.60
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01da008468-03)
  • National Institute on Drug Abuse (DA-08468, DA 14637, R01DA014637)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
dopamine D2 receptor, cocaine self-administration, cocaine dependence, rhesus monkeys, receptor availability, cocaine reinforcement, abstinence, individual differences, dopaminergic system, chronic cocaine exposure
MeSH terms
Animals, Behavior, Animal, Brain, Cocaine, Food, Humans, Lorazepam, Macaca mulatta, Male, Reinforcement, Psychology, Self Administration, Time Factors, Behavior, Addictive, Receptors, Dopamine D2, GABA Modulators, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review